Chronic obstructive pulmonary disease and Psoriasis

Summary:

Psoriasis is found among people with Chronic obstructive pulmonary disease, especially for people who are female, 60+ old.

The study analyzes which people have Psoriasis with Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 189 people who have Chronic obstructive pulmonary disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

189 people who have Chronic Obstructive Pulmonary Disease and Psoriasis are studied.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,700 drugs and 2,007 conditions by eHealthMe.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,274 drugs and 1,581 conditions by eHealthMe.

Number of Psoriasis in Chronic obstructive pulmonary disease reports submitted per year:

Would you have Psoriasis when you have Chronic obstructive pulmonary disease?

Gender of people who have Chronic obstructive pulmonary disease and experienced Psoriasis *:

Click here to view

Age of people who have Chronic obstructive pulmonary disease and experienced Psoriasis *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

Related studies

Treatments, associated drugs and conditions:

Chronic obstructive pulmonary disease (180,000 reports)
Psoriasis (412,216 reports)

COVID vaccines that are related to Psoriasis:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Psoriasis (2,274 drugs)

Common conditions associated with Psoriasis:

Rheumatoid arthritis: 6,377 reports
High blood pressure: 3,552 reports
Crohn's disease: 3,134 reports
Pain: 1,905 reports

All the conditions that are associated with Psoriasis:

Psoriasis (1,581 conditions)

How the study uses the data?

The study is based on Psoriasis and Chronic obstructive pulmonary disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.